In vitro estimations of in vivo jet nebulizer efficiency using actual and simulated tidal breathing patterns

Journal of Aerosol Medicine: Deposition, Clearance, and Effects in the Lung

Volumn 18, Issue 4, 2005, Pages 427-438

  Bosco, Andrew P ^a   Rhem, Rod G ^a   Dolovich, Myrna B ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

Aerosols; And laser diffraction; Breath simulation; Cascade impaction; Corticosteroids; In vitro model; Nebulizers

Indexed keywords

LEVALBUTEROL; OXYGEN;

ADULT; ARTICLE; ASSAY; ASTHMA; BREATHING; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MALE; MONITOR; NEBULIZER; PARTICLE SIZE; SIMULATION; SIMULATOR;

ADMINISTRATION, INHALATION; ADULT; AEROSOLS; ALBUTEROL; CHEMISTRY, PHARMACEUTICAL; DRUG DELIVERY SYSTEMS; FEMALE; HUMANS; MALE; MODELS, BIOLOGICAL; NEBULIZERS AND VAPORIZERS; PARTICLE SIZE; RESPIRATION; TIDAL VOLUME;

EID: 29844444188     PISSN: 08942684     EISSN: None     Source Type: Journal    
DOI: 10.1089/jam.2005.18.427     Document Type: Article

References (29)

1. Jendle, J., B.E. Karlberg, J. Persliden, et al. 1995. Delivery and retention of an insulin aerosol produced by a new jet nebulizer. J. Aerosol Med. 8:243-254.
2. Laube, B.L., G.W. Benedict, and A.S. Dobs. 1998. Time to peak insulin level, relative bioavailability, and effect of site of deposition of nebulized insulin in patients with non insulin-dependent diabetes mellitus. J. Aerosol Med. 11:153-173.
3. Aitken, M.L., R.B. Moss, D.A. Waltz, et al. 2001. A phase I study of aerosolized administration of tgAAVCF to cystic fibrosis subjects with mild lung disease. Hum. Gene Ther. 12:1907-1916.
4. Rudolph, C., R.H. Muller, and J. Rosenecker. 2002. Jet nebulization of PEI/DNA polyplexes: physical stability and in vitro gene delivery efficiency. J. Gene Med. 4:66-74.
5. Dennis, J.H. 1995. Drug nebulizer design and performance: British enhanced jet vs. constant output jet vs. ultrasonic. J. Aerosol Med. 8:277-280.
6. O'Callaghan, C. 1995. Problems with drug delivery from nebulizers and spacers. J. Aerosol Med. 8:301-302.
7. Newnham, D.M., and Lipworth B.J. 1994. Nebulizer performance, pharmacokinetics, airways and systemic effects of salbutamol given via a novel nebulizer system (Ventstream). Thorax 49:762-770.
8. O'Callaghan, C., and P.W. Barry. 1997. The science of nebulized drug delivery. Thorax 52:S31-S44.
9. Knoch, M., and E. Wunderlich. 1995. Effects of age related breathing parameters on the performance of a new nebulizer system: an in-vitro study. J. Aerosol Med. 8:285-288.
10. Mercer, T.T., R.F. Goddard, and R.L. Flores. 1969. Effect of auxiliary airflow on the output characteristics of compressed air nebulizers. Ann. Allergy 27:211-217.
11. Nikander, K., J. Denyer, M. Everard, et al. 2000. Validation of a new breathing simulator generating and measuring inhaled aerosol with adult breathing patterns. J. Aerosol Med. 13:139-146.
12. Nikander, K., J. Denyer, N. Smith, et al. 2001. Breathing patterns and aerosol delivery: impact of regular human patterns, and sine and square waveforms on rate of delivery. J. Aerosol Med. 14:327-333.
13. Barry, P.W., and C. O'Callaghan. 1998. Drug output from nebulizers is dependent on the method of measurement. Eur. Respir. J. 12:463-466.
14. Sangwan, S., R. Condos, and G.C. Smaldone. 2003. Lung deposition and respirable mass during wet nebulization. J. Aerosol Med. 16:379-386.
15. O'Callaghan, C., J. White, J. Jackson, et al. 2002. The output of flunisolide from different nebulizers. J. Pharm. Pharmacol. 54:565-569.
16. Smaldone, G.C. 1994. Drug delivery by nebulization: "reality testing." J. Aerosol Med. 7:213-216.
17. Coates, A.L., C.F. MacNeish, P.D. Allen, et al. 1999. Do sinusoidal models of respiration accurately reflect the respiratory events of patients breathing on nebulizers? J. Aerosol Med. 12:265-273.
18. Cochrane, G.M. 1997. Compliance with nebulized therapy. Eur. Respir. Rev. 7:383-384.
19. Roth, A.P., C.F. Lange, and W.H. Finlay. 2003. The effect of breathing pattern on nebulizer drug delivery. J. Aerosol Med. 16:325-339.
20. Dennis, J.H. 1998. A review of issues relating to nebulizer standards. J. Aerosol Med. 11:S73-S79.
21. Denyer, J., A. Dyche, and K. Nikander. 1997. Breathing patterns in adult patients. J. Aerosol Med. 10:99.
22. Keller, M., J. Jauerig, K. Schueepp, et al. 2004. Using infant deposition models to improve inhaler system design. Respir. Drug Deliv. IX:221-231.
23. Finlay, W.H., K.W. Stapleton, and P. Zuberbuhler. 1997. Predicting regional lung dosages of a nebulized suspension: Pulmicort® (Budesonide). Partic. Sci. Technol. 15:243-251.
24. Barry, P.W., and C. O'Callaghan. 1998. The output of budesonide from nebulizers. J. Allergy Clin. Immunol. 102:321-322.
25. Nikander, K., M. Turpeinen, and P. Wollmer. 1999. The conventional ultrasonic nebulizer proved inefficient in nebulizing a suspension. J. Aerosol Med. 12:47-53.
26. Smaldone, G.C., M. Cruz-Rivera, and K. Nikander. 1998. In vitro determination of inhaled mass and particle distribution for budesonide nebulizing suspension. J. Aerosol Med. 11:113-125.
27. Archer, A., J.P. Mitchell, M.W. Nagel, et al. 1998. Performance of a new air entrainment small volume nebulizer. Eur. Respir. J. 12:68(abst).
28. Geller, D., and B. Kesser. 2001. Comparison of output from 4 different reservoir type nebulizers. Am. J. Respir. Crit. Care Med. 163:A444.
29. Rau, J.L., A. Ari, and R.D. Restrepo. 2004. Performance comparison of nebulizer designs: constant-output, breath-enhanced, and dosimetric. Respir. Care 49:174-179.